Russian Lead losing punch; Veronica Skvortsova fol
Post# of 72440
(Total Views: 518)
Posted On: 02/18/2021 7:47:42 PM
Russian Lead losing punch; Veronica Skvortsova follow-up- January 2021
For various reasons, two cited below, I have growing doubts about the link between Veronica Skvortsova and Brilacidin. The repeated claims that the “antidote” is a Russian development and a claim that the ”cure” is being administered via nebulizer doesn’t fit neatly into the Brilacidin story.
...The drug that I would like to talk about is the first etiotropic drug that directly affects the virus. In fact, it is an antidote to coronavirus infection," said Veronika Skvortsova, head of the Federal Medical and Biological Agency.
https://112.international/society/almost-half...57963.html
“If clinical trials confirm the effectiveness of this drug, it will be the first safe, effective, direct-acting antiviral drug that has no analogs in the world,” she explained. According to Skvortsova, the drug does not affect the body or human immunity and it has demonstrated over 99% efficacy in animal studies by interfering with the reproduction of the virus. It is assumed that the drug will be used as a solution in a nebulizer several times a day.
https://worldhealth.net/news/russia-developin...g-success/
EDIT: This post is not intended in any way to discredit the Russian Clinical Testing (12/17/2020 start date), that was reported on various boards in the past 24 hours.
For various reasons, two cited below, I have growing doubts about the link between Veronica Skvortsova and Brilacidin. The repeated claims that the “antidote” is a Russian development and a claim that the ”cure” is being administered via nebulizer doesn’t fit neatly into the Brilacidin story.
...The drug that I would like to talk about is the first etiotropic drug that directly affects the virus. In fact, it is an antidote to coronavirus infection," said Veronika Skvortsova, head of the Federal Medical and Biological Agency.
https://112.international/society/almost-half...57963.html
“If clinical trials confirm the effectiveness of this drug, it will be the first safe, effective, direct-acting antiviral drug that has no analogs in the world,” she explained. According to Skvortsova, the drug does not affect the body or human immunity and it has demonstrated over 99% efficacy in animal studies by interfering with the reproduction of the virus. It is assumed that the drug will be used as a solution in a nebulizer several times a day.
https://worldhealth.net/news/russia-developin...g-success/
EDIT: This post is not intended in any way to discredit the Russian Clinical Testing (12/17/2020 start date), that was reported on various boards in the past 24 hours.
(1)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼